Executive readout · one minute
What the filings say
- 8-K earnings release · filed Nov 5, 2026
- Nutex Health reported nine-month 2026 revenue of $644.9 million, down 10.9%, while net income attributable to Nutex Health rose 159% to $152.9 million and operating cash flow reached $188.1 million.
- 10-Q report · filed Nov 5, 2026
- Nutex Health’s arbitration costs totaled $27.8 million for the three months ended September 30, 2026 and $61.4 million for the nine months ended September 30, 2026, compared with $41.9 million and $116.2 million, respectively, in 2025.
The audio replay and transcript follow the call.